Amphastar Pharmaceuticals, Inc.
AMPH
$26.60
$0.682.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.99% | 2.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.99% | 2.28% | |||
| Cost of Revenue | 5.99% | 3.10% | |||
| Gross Profit | 14.05% | 1.45% | |||
| SG&A Expenses | 15.05% | -13.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.46% | -0.75% | |||
| Operating Income | 14.78% | 13.12% | |||
| Income Before Tax | -45.31% | 27.45% | |||
| Income Tax Expenses | -49.87% | 48.92% | |||
| Earnings from Continuing Operations | -44.09% | 22.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -44.09% | 22.72% | |||
| EBIT | 14.78% | 13.12% | |||
| EBITDA | 10.12% | 11.59% | |||
| EPS Basic | -43.52% | 24.53% | |||
| Normalized Basic EPS | 14.59% | 29.32% | |||
| EPS Diluted | -42.19% | 25.49% | |||
| Normalized Diluted EPS | 14.49% | 32.13% | |||
| Average Basic Shares Outstanding | -1.01% | -1.45% | |||
| Average Diluted Shares Outstanding | -0.94% | -3.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||